Has the Option of Low-Dose Tamoxifen Impacted Chemoprevention Uptake Among Women with Breast Intra-Epithelial Neoplasia?

MLA

Connors, Bess M., et al. “Has the Option of Low-Dose Tamoxifen Impacted Chemoprevention Uptake Among Women with Breast Intra-Epithelial Neoplasia?” Annals of Surgical Oncology, vol. 31, no. 13, Dec. 2024, pp. 8866–72. EBSCOhost, https://doi.org/10.1245/s10434-024-16025-x.

APA

Connors, B. M., Thompson, J. L., Miodonski, M. A., Sinco, B., Pleasant, V. A., Williams-Morad, M. A., Hughes, T. M., & Pilewskie, M. L. (2024). Has the Option of Low-Dose Tamoxifen Impacted Chemoprevention Uptake Among Women with Breast Intra-Epithelial Neoplasia? Annals of Surgical Oncology, 31(13), 8866–8872. https://doi.org/10.1245/s10434-024-16025-x

Chicago

Connors, Bess M, Jessica L Thompson, Margaret A Miodonski, Brandy Sinco, Versha A Pleasant, Megan A Williams-Morad, Tasha M Hughes, and Melissa L Pilewskie. 2024. “Has the Option of Low-Dose Tamoxifen Impacted Chemoprevention Uptake Among Women with Breast Intra-Epithelial Neoplasia?” Annals of Surgical Oncology 31 (13): 8866–72. doi:10.1245/s10434-024-16025-x.